Caris Biorepository Research Protocol
Conditions
Cancer · Early Detection of Cancer · Minimal Residual Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of South Alabama, Mobile, Alabama, United States
Southwest Medical Imaging, Scottsdale, Arizona, United States
St. Bernards Medical Center, Jonesboro, Arkansas, United States
CARTI Cancer Center, Little Rock, Arkansas, United States
ObjectiveHealth - ARcare Center for Clinical Research, Little Rock, Arkansas, United States
Lee Memorial Health System, Fort Myers, Florida, United States
Cancer Care of North Florida, Lake City, Florida, United States
Contact: Study coordinator (Natalie Espenship) · Natalie.Espenship@cancercareofnorthflorida.com · 386-755-1655Advent Health, Orlando, Florida, United States
The University of South Florida, Tampa, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
Phoebe Putney Memorial Hospital, Albany, Georgia, United States
Emory University, Atlanta, Georgia, United States
Augusta University Research Institute, Augusta, Georgia, United States
Cancer Center of Middle Georgia, Dublin, Georgia, United States
Hope and Healing Cancer Services, Hinsdale, Illinois, United States
CHRISTUS - St. Frances Cabrini Hospital, Alexandria, Louisiana, United States
Tulane University, New Orleans, Louisiana, United States
CHRISTUS - Highland Medical Center, Shreveport, Louisiana, United States
Mercy Medical Center, Baltimore, Maryland, United States
Sinai Hospital of Baltimore, Baltimore, Maryland, United States
Hattiesburg Clinic, Hattiesburg, Mississippi, United States
Jackson Oncology Associates, Jackson, Mississippi, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
ObjectiveHealth - Premier Health Research, Sparta, New Jersey, United States
CHRISTUS - St. Vincent Regional Cancer Center, Santa Fe, New Mexico, United States
St. Lawrence Health System, Potsdam, New York, United States
National Translational Research Group, Ridge, New York, United States
Altru Health System, Grand Forks, North Dakota, United States
NEO Urology Associates, Boardman, Ohio, United States
Great Lakes Medical Research, Cleveland, Ohio, United States
Bend Memorial Clinic, Bend, Oregon, United States
Clinical Biotechnology Research Institute at RSFH, Charleston, South Carolina, United States
Spartanburg Regional Health Services, Spartanburg, South Carolina, United States
West Cancer Center, Germantown, Tennessee, United States
ObjectiveHealth - Amarillo Premier Research, Amarillo, Texas, United States
CHRISTUS - St. Michael's Health, Texarkana, Texas, United States
CAMC Clinical Trials, Charleston, West Virginia, United States
Mercy Health, Janesville, Wisconsin, United States
Study leads
Matthew Oberley, MD
Principal Investigator
Caris Life Sciences